APA (7th ed.) Citation

S, F., TJ, I., G, P., E, W., RR, P., & M, B. (2022). The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States. Journal of medical economics, 25(1), 755. https://doi.org/10.1080/13696998.2022.2082200

Chicago Style (17th ed.) Citation

S, Farahbakhshian, Inocencio TJ, Poorman G, Wright E, Pathak RR, and Bullano M. "The Budget Impact of Enzyme Replacement Therapy in Type 1 Gaucher Disease in the United States." Journal of Medical Economics 25, no. 1 (2022): 755. https://doi.org/10.1080/13696998.2022.2082200.

MLA (9th ed.) Citation

S, Farahbakhshian, et al. "The Budget Impact of Enzyme Replacement Therapy in Type 1 Gaucher Disease in the United States." Journal of Medical Economics, vol. 25, no. 1, 2022, p. 755, https://doi.org/10.1080/13696998.2022.2082200.